The Effect of Atorvastatin on Androgen Synthesis, Glucose Metabolism and Inflammation in Women With Polycystic Ovary Syndrome (PCOS). A Placebo Controlled Trial.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2012
At a glance
- Drugs Atorvastatin (Primary)
- Indications Polycystic ovary syndrome
- Focus Biomarker; Pharmacodynamics
- 06 Sep 2011 Actual End Date added 1 Jan 2011 as reported by ClinicalTrials.gov.
- 06 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Feb 2010 New trial record